LGVN
USDLongeveron Inc. Class A Common Stock
$1.280-0.059 (-4.421%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.339
High
$1.339
Low
$1.260
Volume
0.31M
Company Fundamentals
Market Cap
19.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.13M
Exchange
NCM
Currency
USD
52-Week Range
Low $1.14Current $1.280High $6.4
Related News
GlobeNewswire
Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
MIAMI, June 09, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related
View more
GlobeNewswire
Longeveron® to Attend BIO International Convention 2025
Focus on potential partnership and strategic opportunities for the Company's stem cell therapy program for Alzheimer's diseaseRecent Type B meeting with FDA provided alignment on a planned single, pivotal Phase 2/3
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.